MedPath

Substudy - Evaluation of Patients With Iliac Vein Thrombosis

Completed
Conditions
Iliac Vein Thrombosis
Registration Number
NCT03148548
Lead Sponsor
Cardioangiologisches Centrum Bethanien
Brief Summary

Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry. Using standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening of thrombophilic disorders were additionally entered into the database.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  • >18 years
  • subjects with iliofermoral thrombosis, which has been proven by objective measurements (Duplex sonography, phlebography, CT/MRT) later than 1996
Exclusion Criteria
  • <18 years
  • > 80 years
  • surface or deep vein thrombosis without affection of pelvis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence and severity of postthrombotic Syndrome after iliofemoral thrombosisup to 20 years after occurrence of iliofemoral thrombosis

The incidence and severity of postthrombotic Syndrome will be measured by te VILALLTA-Score

Secondary Outcome Measures
NameTimeMethod
Distribution of gender in Iliofemoral thrombosissince 1996

Distribution of gender (man or woman)

Distribution of affected side in Iliofemoral thrombosissince 1996

distribution of affected side (left or right side)

Disease-specific quality of life instrument for use in venous diseases of the leg (VEINES-QOL)1 year

A quality of life questionaire comprises 25 items that quantify disease effect on quality of life

Incidence of venous claudication1 year

Walking distance on treadmill

Trial Locations

Locations (1)

Cardioangiologisches Centrum Bethanien

🇩🇪

Frankfurt/Main, Hessen, Germany

Cardioangiologisches Centrum Bethanien
🇩🇪Frankfurt/Main, Hessen, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.